O'Shaughnessy Asset Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-7,964
Closed -$232K 1391
2021
Q4
$232K Sell
7,964
-2,866
-26% -$82K ﹤0.01% 1002
2021
Q3
$234K Sell
10,830
-6,758
-38% -$163K ﹤0.01% 964
2021
Q2
$451K Buy
17,588
+693
+4% +$14.8K 0.01% 703
2021
Q1
$308K Buy
16,895
+12,172
+258% +$202K 0.01% 766
2020
Q4
$54K Buy
+4,723
New +$43.2K ﹤0.01% 1222

Other funds holding CDMO

O'Shaughnessy Asset Management's CDMO Position: Q1 2022 in Review

O'Shaughnessy Asset Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2022, closing a stake of 7,964 shares — an estimated $232K sold.

O'Shaughnessy Asset Management first reported a position in CDMO in Q4 2020 and held it in 5 quarters. The position peaked at $451K in Q2 2021. 193 funds tracked by Wall St. Rank hold CDMO as of Q1 2022.

  • O'Shaughnessy Asset Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • O'Shaughnessy Asset Management sold 7,964 Avid Bioservices, Inc. Common Stock shares in Q1 2022, an estimated $232K.
  • O'Shaughnessy Asset Management first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2020 and held it in 5 quarters.
  • O'Shaughnessy Asset Management's Avid Bioservices, Inc. Common Stock position peaked at $451K in Q2 2021.
  • 193 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2022.

Based on O'Shaughnessy Asset Management's 13F filing for Q1 2022, filed 13 May 2022.